Michele D. Huie
TCOYD Newsletter, Vol. 21, 2007

At a recent TCOYD conference, I was pleased to fiddle with the ACCU-CHEK® Spirit pump made by Disetronic Medical Systems. A smart, compact design, the pump impressed me for a handful of reasons. Of course, it has all the latest features insulin pumps must have these days including multiple basal rate profiles, bolus delivery options, safety checks and alarms, and a clear backlit display.

Candis M. Morello, PharmD & Laura Lafranchise, Pharmacist Student
TCOYD Newsletter, Vol. 21, 2007

Have you ever had a tough time losing weight? This is a common challenge for many people, including those with type 2 diabetes. alli™ (orlistat), pronounced Al-eye, is the first over the counter (OTC) weight loss medication that has ever been approved by the FDA. Combined with a healthy meal plan and regular physical activity (like dancing, walking, swimming, biking, etc.), alli may help people with type 2 diabetes achieve their metabolic goals.

Michele D. Huie
TCOYD Newsletter, Vol. 21, 2007

John B. Buse, MD, PhD, CDE President-Elect, Medicine & Science of the American Diabetes Association Director, Diabetes Care Center and Chief of the Division of Endocrinology, University of North Carolina at Chapel Hill, School of Medicine

Michele D. Huie
TCOYD Newsletter, Vol. 22, 2007

An Interview with TCOYD Medical Advisory Board Member Irl B. Hirsch, MD

“My mom was told in 1980 that we’d be curing diabetes in 5 years. But putting cells from one organism into another organism is very challenging,” says Dr. Irl B. Hirsch, Professor of Medicine, in the Division of Metabolism, Endocrinology and Nutrition at the University of Washington. An internationally recognized diabetes specialist, and researcher, Dr. Hirsch is a frequent author and editor of diabetes articles and publications, and a four-time codirector for TCOYD’s Seattle conferences. He recently gave us the opportunity to ask him some questions about his practice, new developments, and generally how he thinks things are going in diabetes care. I found, after asking a single question, “Why did you go into diabetes care?”, that Dr. Hirsch didn’t need much prompting. The “interview” that follows serves as this issue’s look at one of TCOYD’s medical advisory board members.

Susan Phillips, MD
TCOYD Newsletter, Vol. 22, 2007

Part I: On The Rise In The Very Young

Type 1 diabetes is the most common form of diabetes affecting children and constitutes approximately 1% of all diagnosed cases of diabetes in the United States. Recent data on the worldwide incidence of T1DM reveals a shift in its incidence rates among very young children.